Status:
UNKNOWN
Neurofeedback in Visual Snow
Lead Sponsor:
University of Zurich
Conditions:
Visual Snow Syndrome
Neuro-Ophthalmology
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Visual snow (VS) is a distressing, life-impacting condition with unrelenting and persistent disturbing visual phenomena. Disease onset is usually around age 20 and is characterized by continuous perce...
Detailed Description
Currently, there is no pharmacological or non-pharmacological treatment available that significantly reduces the high disease burden produced by VS. Thus, there is an unmet need for an appropriate int...
Eligibility Criteria
Inclusion
- Patients with VS (≥ 18 to ≤ 60 years), which can read and sign the informed consent form.
- Male and female
- Healthy controls (≥ 18 to ≤ 60 years), which can read and sign the informed consent form.
Exclusion
- MR exclusion criteria (patients only): metallic items in the body (i.e. eye splinter, MR incompatible implants), pacemaker, claustrophobia).
- pregnant participants
- participants suffering from a degenerative disorder of the Central Nervous System, such as Stroke, Multiple Sclerosis, Parkinson's Disease, Alzheimer's Disease and Huntington's Disease and with major psychiatric disorders such as schizophrenia, depression, or anxiety disorder requiring pharmacological treatment (psycho-pharmaca).
Key Trial Info
Start Date :
January 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04902365
Start Date
January 14 2022
End Date
December 30 2023
Last Update
June 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland, 8091